Kidney Biopsy Market Share, Trends And Growth By 2034


Use Code ONLINE20 to Save 20% On Global Market Reports – Gain Access to Trusted Market Data, Growth Indicators, and Industry Analytics

What Is the Forecasted Market Size of the Kidney Biopsy Market by 2029?
The kidney biopsy market size has grown strongly in recent years. It will grow from $2.14 billion in 2024 to $2.26 billion in 2025 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to increased chronic kidney diseases, rise in awareness about early diagnosis, surge in geriatric population, expansion of healthcare infrastructure, enhanced government initiatives for kidney disease management, and rise in awareness of kidney health.

The kidney biopsy market size is expected to see strong growth in the next few years. It will grow to " $2.75 billion in 2029 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to increasing prevalence of kidney diseases, rising healthcare expenditure, growing awareness about early diagnosis, expanding geriatric population, rising demand for minimally invasive procedures, and increasing research activities. Major trends in the forecast period include technological advancements in biopsy techniques, adoption of minimally invasive procedures, advancements in imaging technologies, integration of artificial intelligence for better precision, and technological innovations in biopsy devices.

Get your free report sample today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16458&type=smp

What Are the Major Growth Drivers for the Kidney Biopsy Market?
The rise in the incidence of renal cancer is expected to propel the growth of the kidney biopsy market going forward. Renal cancer is characterized by the uncontrolled growth of abnormal kidney cells. The rise in renal cancer is attributed to factors such as changes in lifestyle, environmental toxins, and better detection techniques that result in more diagnoses. A kidney biopsy helps diagnose and manage renal cancer by confirming the presence of cancerous cells, determining cancer grade, planning treatment, monitoring treatment response, and providing prognostic information. For instance, according to Cancer Research UK, a UK-based cancer research organization, the new kidney cancer cases are expected to increase from approximately 16,300 in 2023 to about 21,900 in 2025. Therefore, the rise in the incidence of renal cancer is driving the growth of the kidney biopsy market.

Which Key Segments Are Included in the Kidney Biopsy Market Analysis?
The kidney biopsymarket covered in this report is segmented –

1) By Type: Percutaneous Biopsy; Surgical Biopsy
2) By Indication: Kidney Failure; Kidney Transplant; Hematuria; Proteinuria
3) By End-User: Hospitals And Clinics; Urology Centers; Tertiary Care Centers; Other End-Users

Subsegments:
1) By Percutaneous Biopsy: Ultrasound-Guided Biopsy; CT-Guided Biopsy; MRI-Guided Biopsy
2) By Surgical Biopsy: Open Kidney Biopsy; Laparoscopic Kidney Biopsy

What New Market Trends Are Emerging in the Kidney Biopsy Market?
Major companies operating in the kidney biopsy market are developing innovative platforms by integrating with artificial intelligence (AI) to enhance diagnostic accuracy, streamline procedures, and improve patient outcomes. Artificial intelligence (AI) enhances kidney biopsy by improving image analysis, providing diagnostic support, aiding in treatment planning, offering predictive analytics, and advancing research in kidney diseases. For instance, in March 2024, Aiosyn, a Netherlands-based software company, launched the NephroPath platform. The NephroPath platform uses computational pathology algorithms to analyze histological biomarkers in kidney biopsies, including identifying tissue types, measuring interstitial fibrosis, and precisely counting and assessing glomeruli. This AI-driven analysis ensures consistent, detailed, and reproducible scoring of renal pathology biomarkers, overcoming the drawbacks of traditional scoring methods and observer subjectivity.

Who Are the Leading Market Participants in the Kidney Biopsy Market?
Major companies operating in the kidney biopsy market are Cardinal Health, Pfizer Inc., Merck & Co. Inc., Thermo Fisher Scientific Inc., AstraZeneca, Medtronic, Siemens Healthcare Private Limited, Becton, Dickinson and Company, Stryker Healthcare, Baxter International Inc., Boston Scientific Corporation, F. Hoffmann-La Roche Ltd., Zimmer Biomet, Agilent Technologies Inc., Olympus Corporation, Hitachi High-Tech Corporation, Beckman Coulter Inc., B. Braun, Sysmex Corporation, Cook Medical, Bio-Rad Laboratories Inc., Integra LifeSciences Corporation, Merit Medical Systems, Leica Biosystems Nussloch GmbH, Argon Medical Devices Inc., BioGenex

Get the detailed kidney biopsy market report today
https://www.thebusinessresearchcompany.com/report/kidney-biopsy-global-market-report

Which Regions Are Driving the Highest Demand in the Kidney Biopsy Market?
North America was the largest region in the kidney biopsy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney biopsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Comments

Post a Comment

Popular posts from this blog

Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Scope, Share Analysis And Growth 2025

Image
Focused on real-world business use, this report highlights what’s changing in the hypertrophic cardiomyopathy (hcm) therapeutics market and what companies should prepare for next. What Is The Projected Market Size & Growth Rate Of The Hypertrophic Cardiomyopathy (HCM) Therapeutics Market? The hypertrophic cardiomyopathy (hcm) therapeutics market size has grown marginally in recent years. It will grow from $1.34 billion in 2024 to $1.37 billion in 2025 at a compound annual growth rate (CAGR) of 1.5%. The growth in the historic period can be attributed to diagnostic advancements, increased disease awareness, drug development and approvals, rising healthcare expenditure, government initiatives and funding. The hypertrophic cardiomyopathy (hcm) therapeutics market size is expected to see steady growth in the next few years. It will grow to $1.56 billion in 2029 at a compound annual growth rate (CAGR) of 3.4%. The growth in the forecast period can be attributed to genetic research and ...
Read more

Glycomics or Glycobiology Market Scope, Share Analysis And Growth 2025

Image
Backed by rigorous analysis and deep industry knowledge, this study is designed to support growth and investment decisions in the glycomics or glycobiology market. How Big Is The Glycomics or Glycobiology Market In 2025? The glycomics or glycobiology market size has grown rapidly in recent years. It will grow from $1.85 billion in 2024 to $2.13 billion in 2025 at a compound annual growth rate (CAGR) of 14.9%. The growth in the historic period can be attributed to increased awareness of glycans in biological systems, expansion of glycan-related database and resources, rise in collaborative research initiatives, advancements in glycan synthesis and engineering, glycan biomarker identification. The glycomics or glycobiology market size is expected to see rapid growth in the next few years. It will grow to $3.99 billion in 2029 at a compound annual growth rate (CAGR) of 17.0%. The growth in the forecast period can be attributed to glycan-focused artificial intelligence (AI) and data analy...
Read more

Smart Crop Monitoring Market Overview, Analysis And Demand By 2034

Image
Aimed at strategic decision-makers, this report explores current opportunities, emerging trends, and market dynamics shaping the smart crop monitoring sector. How Big Is The Smart Crop Monitoring Market In 2025? The smart crop monitoring market size has grown rapidly in recent years. It will grow from $3.47 billion in 2024 to $4.09 billion in 2025 at a compound annual growth rate (CAGR) of 18.0%. The growth in the historic period can be attributed to rising demand for high crop production, increasing global population, significant growth in IOT technology, rising need for sustainable agricultural practices, and increasing regulatory pressures. The smart crop monitoring market size is expected to see rapid growth in the next few years. It will grow to $7.83 billion in 2029 at a compound annual growth rate (CAGR) of 17.6%. The growth in the forecast period can be attributed to the development of automated irrigation systems, the growing trend of farm-to-table movements, an increase in ag...
Read more